Dual-encapsulated liposomal vitamin C increases comparative oral exposure in a randomised crossover study in healthy adults

This study characterised DELT, a rice-protein-associated dual-encapsulation vitamin C powder, and compared its in vitro properties and short-term pharmacokinetic profile with conventional liposomal and reference vitamin C formulations. Physicochemical characterisation included particle size, polydispersity, surface charge, morphology and solid-state analysis. Vitamin C content, operational encapsulation efficiency, in vitro release and accelerated stability were also evaluated. An exploratory, randomised, double-blind, three-treatment, three-period crossover study was conducted in 12 healthy adults following a single oral dose containing 350 mg vitamin C. Re-dispersed DELT had a mean hydrodynamic diameter of 210.0 ± 33.4 nm and a polydispersity index of 0.025. Measured vitamin C content was 71.3 ± 1.0% w/w, and operational encapsulation efficiency was 87.8%. In phosphate buffer at pH 6.8, DELT released 35.0 ± 3.5% of its vitamin C by 8 h, compared with 78.8 ± 4.6% for unformulated vitamin C. During 8 months of accelerated storage at 40 °C/65% relative humidity, vitamin C content changed from 71.23% to 71.17% w/w. In the clinical study, mean baseline-corrected maximum plasma concentrations were 16.90 ± 1.90 µg/mL for DELT, 9.92 ± 1.10 µg/mL for conventional liposomal vitamin C and 2.62 ± 0.76 µg/mL for reference vitamin C. Corresponding areas under the concentration–time curve up to the last measured time point were 126.32 ± 19.60, 68.11 ± 8.46 and 11.43 ± 2.60 µg·h/mL, respectively. Pairwise comparisons were statistically significant ( p < 0.0001). These exploratory findings demonstrate differences in formulation characteristics, release behaviour and measured short-term plasma exposure. Larger studies with longer sampling, validated analytical procedures and compositionally matched comparators are required to confirm the pharmacokinetic findings and investigate the contribution of individual formulation components. Trial registration : Clinical Trials Registry–India, CTRI/2025/12/098688.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-80960-w
Primary Topic
Microencapsulation and Drying Processes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual-encapsulated liposomal vitamin C increases comparative oral exposure in a randomised crossover study in healthy adults

Ajanya Saji, Sandeep Gopalakrishnan, Kalpana Balakrishnan, Nandu Bhaskar Andalattu Vijayan et al.
2 links
Scientific Reports
Microencapsulation and Drying Processes
article

Dual-encapsulated liposomal vitamin C increases comparative oral exposure in a randomised crossover study in healthy adults

Ajanya Saji, Sandeep Gopalakrishnan, Kalpana Balakrishnan, Nandu Bhaskar Andalattu Vijayan, Gaanappriya Mohan, Sreya Erezhath Sarun
article en

Abstract

This study characterised DELT, a rice-protein-associated dual-encapsulation vitamin C powder, and compared its in vitro properties and short-term pharmacokinetic profile with conventional liposomal and reference vitamin C formulations. Physicochemical characterisation included particle size, polydispersity, surface charge, morphology and solid-state analysis. Vitamin C content, operational encapsulation efficiency, in vitro release and accelerated stability were also evaluated. An exploratory, randomised, double-blind, three-treatment, three-period crossover study was conducted in 12 healthy adults following a single oral dose containing 350 mg vitamin C. Re-dispersed DELT had a mean hydrodynamic diameter of 210.0 ± 33.4 nm and a polydispersity index of 0.025. Measured vitamin C content was 71.3 ± 1.0% w/w, and operational encapsulation efficiency was 87.8%. In phosphate buffer at pH 6.8, DELT released 35.0 ± 3.5% of its vitamin C by 8 h, compared with 78.8 ± 4.6% for unformulated vitamin C. During 8 months of accelerated storage at 40 °C/65% relative humidity, vitamin C content changed from 71.23% to 71.17% w/w. In the clinical study, mean baseline-corrected maximum plasma concentrations were 16.90 ± 1.90 µg/mL for DELT, 9.92 ± 1.10 µg/mL for conventional liposomal vitamin C and 2.62 ± 0.76 µg/mL for reference vitamin C. Corresponding areas under the concentration–time curve up to the last measured time point were 126.32 ± 19.60, 68.11 ± 8.46 and 11.43 ± 2.60 µg·h/mL, respectively. Pairwise comparisons were statistically significant ( p < 0.0001). These exploratory findings demonstrate differences in formulation characteristics, release behaviour and measured short-term plasma exposure. Larger studies with longer sampling, validated analytical procedures and compositionally matched comparators are required to confirm the pharmacokinetic findings and investigate the contribution of individual formulation components. Trial registration : Clinical Trials Registry–India, CTRI/2025/12/098688.

Scientific Reports
K.S. Rangasamy College of Technology (IN), University of Wisconsin–Milwaukee (US)
Good health and well-being
Microencapsulation and Drying Processes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon